P1396: CD33-DELETED HEMATOPOIETIC STEM AND PROGENITOR CELLS DISPLAY NORMAL ENGRAFTMENT AFTER HEMATOPOIETIC CELL TRANSPLANT (HCT) AND TOLERATE POST-HCT GEMTUZUMAB OZOGAMICIN (GO) WITHOUT CYTOPENIAS

• Guenther Koehne,
• Benjamin Tomlinson,
• Hyung Suh,
• Divya Koura,
• Christina Cho,
• Nadia M Bambace,
• Léa Bernard,
• Nirali N Shah,
• Roland Walter,
• John Dipersio,
• Miguel-Angel Perales,
• Michael R Loken,
• Kyle Breitschwerdt,
• Sritama Nath,
• Glen Raffel,
• Brenda W Cooper

Affiliations

Guenther Koehne

1 Miami Cancer Institute, Miami, United States

Benjamin Tomlinson

2 Sideman Cancer Center, Cleveland, United States

Hyung Suh

3 John Theurer Cancer Center

Divya Koura

4 UCSD Moores Cancer Center

Christina Cho

3 John Theurer Cancer Center

Nadia M Bambace

5 Miami Cancer Institute

Léa Bernard

6 University of Montreal and Maisonneuve-Rosemont Hospital

Nirali N Shah

7 National Cancer Institute, NIH

Roland Walter

8 Fred Hutchinson Cancer Center

John Dipersio

9 Washington University School of Medicine

Miguel-Angel Perales

10 Memorial Sloan Kettering Cancer Center

Michael R Loken

11 Hematologics, Inc

Kyle Breitschwerdt

12 Vor Biopharama

Sritama Nath

12 Vor Biopharama

Glen Raffel

12 Vor Biopharama

Brenda W Cooper

2 Sideman Cancer Center, Cleveland, United States